Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
All 4,307 are listed on earlier pages.
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2026-10-30
Study completion Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06773663
2026-10-30
Primary completion A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07026968
2026-10-30
Primary completion Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07290751
2026-10-30
Primary completion A Study of VCT220 in Participants With Hypertension and Obesity or Overweight Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07360275
2026-10-30
Study completion A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07372326
2026-10-30
Study completion Blended Resources for Integrated Diabetes Guidance and Empowerment Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07373379
2026-10-30
Primary completion High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism. Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07381712
2026-10-30
2026-10-30
Study start Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07751965
2026-10-30
Study start Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07806279
2026-10-30
Study start A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07923357
2026-10
Primary completion CardioFocus HeartLight Post-Approval Study Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03168659
2026-10-31
Primary completion Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03183895
2026-10-31
Study completion Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT03621501
2026-10-31
Primary completion Advancing Postmenopausal Preventive Therapy Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04103476
2026-10-31
Primary completion Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04217421
2026-10
Primary completion Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04763200
2026-10-31
Study completion Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05119179
2026-10-31
Primary completion Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05119179
2026-10
Study completion Precise Procedural and PCI Plan (P4) Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05253677
2026-10
Study completion To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05486000
2026-10
Primary completion To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05486000
2026-10-31
Primary completion Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05598333
2026-10
Study completion A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06037252
2026-10
Study completion Evaluation of the Ton-bridge Carotid Stent for Carotid Artery Stenosis Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06365697
2026-10-31
Study completion Study of JK07 in Patients With Chronic Heart Failure Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06369298
2026-10-31
Primary completion Study of JK07 in Patients With Chronic Heart Failure Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06369298
2026-10-31
Study completion Tirofiban for Successful Endovascular Stroke Thrombectomy Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06373042
2026-10
Study completion EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06386874
2026-10
Study completion Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06479343
2026-10
Study completion Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06616961
2026-10
Primary completion BIO|MASTER.CSP Study Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06620237
2026-10
Study completion Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06645249
2026-10
Study completion Standardized Goal-Directed vs. Self-Directed Valsalva Maneuver for the Assessment of Patent Foramen Ovale Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06670781
2026-10
Primary completion Standardized Goal-Directed vs. Self-Directed Valsalva Maneuver for the Assessment of Patent Foramen Ovale Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06670781
2026-10
Primary completion Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06866236
2026-10
Primary completion Novel Chinese Medicine Formula for Diabetes Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06978023
2026-10
Primary completion NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07018596
2026-10
Study start Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR) Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07083765
2026-10
Primary completion Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07090161
2026-10-31
Study completion Post-stroke Nurse-led Rehabilitation to Improve Functional Activity and Community Participation in Bangladesh Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07384650
2026-10
Study start Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07389941
2026-10-31
Primary completion Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07396337
2026-10-31
Study completion Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07508254
2026-10-31
Study start Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy Registry record
Expected 2026-10-31; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07511543
2026-10
Study completion HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07546929
2026-10
Primary completion HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07546929
2026-10
Study start Multi-Site STARgraft (10401) Trial Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07557862
2026-10
Study start Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial Fibrillation Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07575828
2026-10-31
2026-10
Study start Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07735338
2026-10
Study start ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms. Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07737964
2026-10
Study start Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07740330
2026-10-31
2026-10
2026-10
Study start Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood Pressure (AOBP) Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07822022
2026-10
Study start REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07834372
2026-10
Study start Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07835581
2026-10
2026-10
Study start AI-Based Personalized Self-Management for Patients With Heart Failure Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07841665
2026-10
Study start A Study of HRS-4729 Injection in Participants With Type 2 Diabetes Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07843862
2026-10
Study start A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney Disease Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07848880
2026-10
Study start Vortosiran for VTE Prevention Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07850453
2026-10
Study start Upper Extremity Orthoses Combined With Occupational Therapy in Subacute Stroke Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07864090
2026-10
Study start Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: Clinical Efficacy and Left Atrial Function Protection Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07865221
2026-10
Study start Tolerability and Safety of Nano-Tocotrienols Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07888426
2026-10
Study start Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel Disease Registry record
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07891650
2026-10-31
2026-10
Primary completion ORION-4 (inclisiran outcome trial)
Expected 2026-10; that period ended on 2026-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-14 .
Source: A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
2026-11-01
Study completion Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04676880
2026-11-01
Primary completion ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05686317
2026-11-01
Primary completion Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06705010
2026-11-01
Primary completion SIRAKI 02 Posthoc Analysis. Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06781294
2026-11-01
Study start Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06882772
2026-11-01
Study start Metabolic Surgery for Atrial Fibrillation Elimination Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07027969
2026-11-01
Primary completion The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07103655
2026-11-01
Study completion SLGT2i for Neuroprotection in Patients With Acute Ischemic Stroke Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07105917
2026-11-01
Study completion Perioperative Argon Inhalation to Improve Neurocognitive Recovery After Carotid Surgery Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07200180
2026-11-01
Study start Optimal PharmacoTherapy and Invasive Management of Atrial Fibrillation in Patients With Heart Failure Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07238452
2026-11-01
Study start Silicon-based Photon Counting Computed Tomography for Advanced Cardiac Imaging Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07411196
2026-11-01
Study start Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07763405
2026-11-01
Study start Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07852637
2026-11-01
Study start A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07872436
2026-11-01
Study start Haptic-Assisted Virtual Reality Upper-Limb Rehabilitation After Intracerebral Haemorrhage Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07882810
2026-11-01
Study start A Novel Wire-Reinforced Fenestration of a Hybrid Frozen Elephant Trunk Device for Supra-Aortic Branch Vessel Stenting During Aortic Arch Replacement Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07885865
2026-11-01
Study start Superficial Parasternal Block Combined With Rectus Sheath Block for Open Cardiac Surgery Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07890857
2026-11-01
Study start Metformin in Acute Ischemic Stroke Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07899307
2026-11-01
Study start Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07901595
2026-11-01
Study start Implementation Study on Hospital-to-home Advanced Rehabilitation Technologies (ART) Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07904624
2026-11-01
Study start Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07917078
2026-11-01
Study start Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT) Registry record
Expected 2026-11-01; that period ended on 2026-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07920055
2026-11-02
Study start Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch Registry record
Expected 2026-11-02; that period ended on 2026-11-02.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07540416
2026-11-02
Study start Furosemide vs Placebo in Severe Preeclampsia Postpartum Registry record
Expected 2026-11-02; that period ended on 2026-11-02.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07648251
2026-11-02
Study start Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon Registry record
Expected 2026-11-02; that period ended on 2026-11-02.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07890740
2026-11-02
Study start Study of the Safety and Efficacy of Prenofitol Tablets Registry record
Expected 2026-11-02; that period ended on 2026-11-02.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07908433
2026-11-04
Primary completion Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia Registry record
Expected 2026-11-04; that period ended on 2026-11-04.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06772168
2026-11-06
Study start A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin Registry record
Expected 2026-11-06; that period ended on 2026-11-06.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07796477
2026-11-07
Primary completion Grid eXplore Mapping Study Registry record
Expected 2026-11-07; that period ended on 2026-11-07.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07421076
2026-11-09
Study start Negative Pressure Wound Therapy Devices in Total Knee Arthroplasty Registry record
Expected 2026-11-09; that period ended on 2026-11-09.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07770633
2026-11-10
Study completion A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) Registry record
Expected 2026-11-10; that period ended on 2026-11-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06660173